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Community participatory research em-
phasizes communication of study findings
to research participants of vulnerable
populations [1]. Most dissemination activ-
ities in sub-Saharan Africa have occurred
after the completion (or termination) of
randomized clinical trials of a defined
intervention [2–4]. Sharing research find-
ings with participants during observational
research can avoid therapeutic misconcep-
tion [5] as well as evaluate the validity of
research involving knowledge, attitudes, or
behavior through a ‘‘member check’’
procedure in which investigators conduct
interviews regarding the relevancy and
saliency of their findings [6]. Nonetheless,
the communication of research findings to
participants living with HIV enrolled in
observational research in a rural sub-
Saharan African setting is less straightfor-
ward and presents significant challenges
with respect to literacy, language, logistics,
and confidentiality.
We communicated research findings to
540 participants enrolled in an ongoing 7-
year prospective cohort study of HIV
treatment in Mbarara, Uganda. We had
not organized prior dissemination meet-
ings. This participant dissemination meet-
ing was motivated in part by feedback
from a study participant, who said: ‘‘You
have been asking me questions and taking
my blood for years but I do not know
anything about what you have found.’’
Herein, we describe our first approach to
the preparation, logistics, confidentiality
concerns, format, participant responses,
and follow-up of the dissemination pro-
cess.
Study participants in the Uganda Anti-
retroviral Rural Treatment Outcomes
(UARTO) cohort study are adults living
with HIV initiating antiretroviral therapy
(ART) at the Immune Suppression Syn-
drome (ISS) Clinic affiliated with the
Mbarara University of Science and Tech-
nology (MUST) in rural, southwestern
Uganda. The primary objective of the
study is to examine the social, behavioral,
and economic correlates of long-term
adherence to ART using wireless real-time
adherence monitoring and to determine
the extent to which adherence behavior
affects biologic outcomes.
We faced several challenges in reporting
research findings to this population. Com-
plicated scientific concepts needed to be
distilled into simple core messages that
could be easily understood—and not
misinterpreted—by all participants in the
local language (Runyankole), including
those with limited formal education. We
believed written dissemination would be
ineffective since many participants cannot
read, and individual oral communication
to more than 500 participants is overly
resource intensive. Group communication
would be complex both in respect to
confidentiality and logistics of convening
study participants who live within a 60-km
radius catchment area in the context of a
poor transportation infrastructure. Re-
gardless of the mode and format of
communication, accurate translation of
scientific concepts from English into Ru-
nyankole can be a complicated and
lengthy process due to lack of scientific
terminology.
Step One: Exploring
Acceptability, Format, and
Content with Participants
Each of seven research assistants infor-
mally interviewed five to ten of their
participants during routine study visits to
ask them if they would attend a meeting of
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format, venue, and food. The research
assistants explained that only participants,
research staff, and officials would be
included, that the venue would be private,
and that no photos or journalists would be
allowed. The research assistants explored
concerns about confidentiality, specifically
the issue of participants seeing one another
at the event. The vast majority of
participants were comfortable with these
protections and assurances. Most partici-
pants were willing to attend despite the
inherent loss of confidentiality to other
participants. As one participant stated,
‘‘Well, they are living with this disease,
too, and so what can they think about
me?’’
The contents of the dissemination
conference were determined by research
assistants’ probing conversations with par-
ticipants. The participants’ concerns
ranged from the desire to know more
about their lab results, to food supple-
ments, to questions regarding planning for
pregnancy.
Step Two: Ethics Review
The dissemination meeting was dis-
cussed in advance with the chairs of the
Mbarara University of Science and Tech-
nology Institutional Review Committee
(MUST IRC); the assistant executive
secretary of the Uganda National Council
of Science and Technology (UNCST), a
national agency for the oversight of all
research conducted in Uganda); and the
Partners Human Research Committee.
Participants and human subjects commit-
tee chairpersons were informed that we
would take reasonable measures to protect
confidentiality and that participation was
entirely voluntary, but that we could not
guarantee confidentiality. Local human
subjects committee and UNCST leader-
ship were invited because the idea for the
conference took shape during an informal
discussion with the UNCST assistant
executive secretary about balancing the
need for dissemination and protections
against inadvertent HIVserostatus disclo-
sure. We discussed the conference in
advance with the chair of the Partners
and MUST human subjects committees to
confirm that there was no objection to
having the event.
Step Three: Preparation of
Findings and Content
Each study co-investigator was part-
nered with one or two study research
assistants to develop the content of their
presentation. Each of ten co-investigators,
both Ugandan and North American,
prepared a 15-minute summary of findings
related to their area of expertise. The
research assistants then undertook the
time-intensive task of translating the ma-
terial from English to Runyankole. Special
attention was devoted to communicating
at a level that would be meaningful to the
study participants, while still scientifically
accurate. In the process, we recognized
several ambiguities in translation for
common questions. We then undertook
the standardized translation of scientific
terms into Runyankole and intend to
incorporate these into the research proto-
col and consent forms.
The content included findings published
over the prior 7 years as well as prelim-
inary findings currently in preparation for
publication. Topics included: 1) why
people missed HIV antiretroviral medica-
tion doses, with particular attention to how
social support helps people overcome
structural and economic barriers to ad-
herence [7,8]; 2) the consequences of
short-term interruptions in treatment [9];
3) how the real-time adherence monitor
functions and how specific improvements
in the device have led to less frequent
communication failures (and, therefore,
less frequent home visits to collect blood
specimens) [10,11]; 4) how viral suppres-
sion, co-infections, and viral rebound
affect the recovery of the immune system,
and how this affects survival and living
with HIV [12]; 5) how the collection of
stool helps us understand interactions
between micro-organisms in the intestine,
HIV, and the immune system; 6) the
negative impacts of alcohol on adherence,
and how food insecurity affects many
aspects of life, including adherence [13–
16]; 7) how depression compounds HIV
stigma, and how both depression and
stigma prevent people from accessing
social support to overcome structural
barriers to sustained ART adherence
[13]; and 8) how sexual behavior and
fertility rates change as physical and
mental health improve on ART [17,18].
Step Four: Invitation
All participants were invited to the
event. Each research assistant called or
visited approximately 80 participants to
invite them. These invitations were fol-
lowed by written letters signed by the
Ugandan and North American principal
investigators to formalize the invitations.
The research assistants recorded invitation
acceptance, concerns about the meeting,
and transport requirements to attend the
meeting.
Among 540 currently active partici-
pants, we were unable to contact 53 of
them, the majority of whom are known to
be lost to follow-up in the cohort. A total
of 477 participants were successfully con-
tacted, and an additional ten heard about
the event from other participants. Twelve
participants declined the invitation: six
declined for fear of disclosure and stigma,
and six declined due to inflexible work and
personal obligations.
The assistant executive secretary of
UNCST, chair of MUST-IRC, dean of
the MUST Faculty of Medicine, the
MUST vice chancellor, the US National
Institute of Mental Health (NIMH) project
officer, the ISS clinic director, and several
ISS Clinic staff were invited. All attended
except for the MUST vice chancellor, who
sent the MUST registrar as his represen-
tative.
Step Five: Facilitating
Transportation and Arrival
Each participant was offered the choice
of transportation to the meeting by a study
driver or reimbursement for public trans-
portation. Participants using public trans-
portation gathered at the clinic in the early
morning and were shuttled to the venue.
The vast majority of participants chose
public transportation. They arrived earlier
than requested and dressed in traditional,
formal Runyankole attire. Research staff
individually greeted each participant at a
decorated entrance. Of the 475 partici-
Summary Points
N Sharing research findings with participants living with HIV enrolled in
observational research in rural sub-Saharan Africa presents significant
challenges with respect to literacy, language, logistics, and confidentiality.
N Preparation of findings into the local language improved communication
between investigators and staff.
N Oral dissemination to 466 participants during a meeting modeled after a
traditional wedding event was enthusiastically received by participants, was a
rewarding experience for the research team, and identified new areas for
investigation.
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did not attend, for a total of 466 study
participants in attendance.
Step Six: Program Agenda and
Format
The event was modeled after a typical
Runyankole wedding celebration to create
a familiar and comfortable setting, which
included a raised and covered stage with
rows of covered seating arranged perpen-
dicular to the stage on either side.
Decorations consisted of streamers and
floral arrangements.
The meeting was facilitated by a
Ugandan physician well known to the
study participants through his work at the
clinic. For each of several topics, he
introduced the investigator and the re-
search assistant partners, who approached
the stage together. The research assistants
presented the information in Runyankole
with the investigators standing at their
sides. Throughout the meeting, research
staff translated and recorded questions
raised by participants. Questions were
collected by the facilitator and communi-
cated to the investigators. The investiga-
tors selected representative questions and
answered in English, and these answers
were then translated orally into Runyan-
kole for the study participants.
As is customary in southwest Uganda,
there were two breaks in the presentations
for entertainment. UARTO research as-
sistants performed a local Bakiga dance
that many participants and investigators
joined spontaneously. A song and drum-
ming performance group, comprised of 15
patients from the ISS Clinic, performed in
partnership with a North American re-
searcher (PWH) who accompanied them
on trumpet. They sang two original songs
about youth and HIV prevention as well
as the history of the UARTO study.
After the presentation and questions, all
participants; the research staff; represen-
tatives from MUST IRC, UNCST, and
MUST; and the Ugandan and North
American investigators shared a tradition-
al Ugandan buffet lunch. Participants,
investigators, and guests were invited to
leave their handprint in bright colors on
one of several large banners to symbolize
the gathering (Figure 1). Participants were
given certificates of completion with their
printed names, and both the Ugandan and
North American principal investigators
signed each certificate. Permission to print
the named certificate was requested of
each participant beforehand. All partici-
pants chose to have their names printed on
the certificate rather than have a certifi-
cate without a name. Transportation
reimbursements were then provided to
each participant. The co-investigators and
staff conducted an informal evaluation of
the event during the reception. Themes
were discussed that evening and the
following day.
Discussion
The informal response from partici-
pants was overwhelmingly positive and
supported by 98% attendance of those
who accepted the invitation. According to
research assistants, there is a consensus
among participants that the dissemination
event should be held annually. Several
participants stated that the event made
them feel like participants in the research
rather than research ‘‘subjects.’’ More
Box 1. Representative Questions from UARTO Participants
Economic assistance & food insecurity
N Is it possible to give us the starting capital so as to do business and buy things
like food or cater for our transport?
N What do I do to have food, if am weak and have no social support but at the
same time I have to take my drugs. What advice do you give?
N We hear that there is support that is given to HIV patients but we don’t see this
support. Where is this support delivered? How can we access this support?
Reproductive goals & PMTCT & transmission risk
N If I produce a child, do I need to share my ARVs [antiretrovirals] with that child
or is the child given other drugs?
N We need some information on how to live with a discordant partner.
N How can a couple where a man is negative and a woman positive produce a
kid?
N How can you help those women who are positive and receiving care but their
husbands have refused to test?
N What can I do to produce a safe baby?
Mental health
N You talked about depression, how can we avoid it?
N I developed a mental problem after initiation of ARVs, which has caused me to
isolate myself from the others and have food insecurity. How are you going to
help?
N I have a child who is HIV positive and taking ARVs and always asks why he is
taking the drugs, every time I keep on dodging him. How then shall I begin
telling him that he has the virus? He is 9 years of age.
Adherence
N It was said that when someone misses drugs, the virus multiplies, when one
starts his drugs, when does the virus go?
General medical questions & HIV complications
N When we start ARVs, we experience things like red lips, fatty abdomen, and
sunken cheeks, and they persist. How can we avoid or manage them?
N Does alcohol affect the ARV drugs that we take?
N How come that the sexual urge increases when someone starts ARV drugs?
N Is it true that someone can be healed from HIV after being prayed for?
Figure 1. Handprints made during dis-
semination project.
doi:10.1371/journal.pmed.1001397.g001
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that the event made them feel respected,
and they personally thanked the North
American principal investigator ‘‘for hon-
oring us today.’’
The handprint banners were hung in
the research offices and the phlebotomy
room in Mbarara and at the MGH Center
for Global Health office in Boston.
Framed segments of the banners were
given to MUST leadership, the MUST
IRC chairperson, UARTO investigators,
the NIMH project officer, and the private
donors who sponsored the event.
The process of preparing the scientific
presentations with the research staff high-
lighted subtle aspects of English–Runyan-
kole language translation. While our study
instruments are routinely translated and
then back translated, we identified addi-
tional points of potential miscommunica-
tion. During this process, we learned that
study participants often ask questions that
research assistants are unprepared and
unauthorized to discuss. The dissemina-
tion conference provided a formal mech-
anism for the research assistants to share
participants’ concerns and questions with
the entire investigator team. As a result of
the meeting, we now routinely review
questions generated by participants in
order to identify additional ambiguities
and generate accurate standardized re-
sponses. We are also pursuing several
areas of investigation based on the partic-
ipants’ feedback, including interventions
related to income generation, food securi-
ty, safely achieving reproductive goals, and
adherence support. We plan to invite
participants to lead more detailed discus-
sions on their perceptions of high impact
research topics during future dissemina-
tions. We also plan to invite additional
stakeholders, including clinic sponsors, to
future conferences. While we do not
suggest that dissemination conferences like
this should be standard for all studies since
we did not include a formal evaluation, we
suggest it as a model for future evaluation.
In summary, the dissemination of our
scientific findings to a cohort of people
with HIV living in rural Uganda was
highly rewarding for participants, research
staff, and investigators. It improved com-
munication between participants and re-
search staff, strengthened the relationship
between research staff and investigators,
and created a sense of community among
participants. Finally, the event generated a
research agenda directly from those most
affected by HIV in a rural, resource-
constrained setting. We recommend this
format as a guide to dissemination of study
findings to study participants in similar
settings.
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